The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Endocannabinoid signalling and the deteriorating brain
Open accessAbstract
Ageing is characterized by the progressive impairment of physiological functions and increased risk of developing debilitating disorders, including chronic inflammation and neurodegenerative diseases. These disorders have common molecular mechanisms that can be targeted therapeutically. In the wake of the approval of the first cannabinoid-based drug for the symptomatic treatment of multiple sclerosis, we examine how endocannabinoid (eCB) signalling controls — and is affected by — normal ageing and neuroinflammatory and neurodegenerative disorders. We propose a conceptual framework linking eCB signalling to the control of the cellular and molecular hallmarks of these processes, and categorize the key components of endocannabinoid signalling that may serve as targets for novel therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Rubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
Self-citationLeptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus
Schmidt-Hieber, C., Jonas, P., & Bischofberger, J. (2004) · Nature · doi:10.1038/nature02553 · Cited by 1,292
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177
Andrew, S. E., Paul Goldberg, Y., Kremer, B., Telenius, H., Theilmann, J., Adam, S., Starr, E., Squitieri, F., Lin, B., Kalchman, M. A., et al. (1993) · Nature Genetics · doi:10.1038/ng0893-398 · Cited by 1,129
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.15 · Cited by 1,059
Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052
Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039
Self-citationIncreasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing
Molofsky, A. V., Slutsky, S. G., Joseph, N. M., He, S., Pardal, R., Krishnamurthy, J., Sharpless, N. E., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature05091 · Cited by 972
De Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., Stott, C. G., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01166.x · Cited by 946
Self-citationHypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH
Zhang, G., Li, J., Purkayastha, S., Tang, Y., Zhang, H., Yin, Y., Li, B., Liu, G., & Cai, D. (2013) · Nature · doi:10.1038/nature12143 · Cited by 834
Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners
Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 805
Targeting the endocannabinoid system: to enhance or reduce?
Di Marzo, V. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798
Self-citationCannabinoid pharmacology: the first 66 years
Pertwee, R. G. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706406 · Cited by 782
Distribution of cannabinoid receptors in the central and peripheral nervous system
Mackie, K. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_10 · Cited by 744
Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
Nomura, D. K., Morrison, B. E., Blankman, J. L., Long, J. Z., Kinsey, S. G., Marcondes, M. C. G., Ward, A. M., Hahn, Y. K., Lichtman, A. H., Conti, B., et al. (2011) · Science · doi:10.1126/science.1209200 · Cited by 727
Salazar, M., Carracedo, A., Salanueva, Í. J., Hernández-Tiedra, S., Lorente, M., Egia, A., Vázquez, P., Blázquez, C., Torres, S., García, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37948 · Cited by 686
With TOR, Less Is More: A Key Role for the Conserved Nutrient-Sensing TOR Pathway in Aging
Kapahi, P., Chen, D., Rogers, A. N., Katewa, S. D., Li, P. W.-L., Thomas, E. L., & Kockel, L. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.05.001 · Cited by 660
Dose-related neurocognitive effects of marijuana use
Bolla, K. I., Brown, K., Eldreth, D., Tate, K., & Cadet, J. L. (2002) · Neurology · doi:10.1212/01.wnl.0000031422.66442.49 · Cited by 608
Mitochondrial CB1 receptors regulate neuronal energy metabolism
Bénard, G., Massa, F., Puente, N., Lourenço, J., Bellocchio, L., Soria-Gómez, E., Matias, I., Delamarre, A., Metna-Laurent, M., Cannich, A., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3053 · Cited by 588
Peripheral cannabinoid receptor, CB2, regulates bone mass
Ofek, O., Karsak, M., Leclerc, N., Fogel, M., Frenkel, B., Wright, K., Tam, J., Attar-Namdar, M., Kram, V., Shohami, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504187103 · Cited by 536
Self-citationJiang, W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25509 · Cited by 527
Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomas
Stella, N. (2010) · Glia · doi:10.1002/glia.20983 · Cited by 527
Self-citationHan, J., Kesner, P., Metna-Laurent, M., Duan, T., Xu, L., Georges, F., Koehl, M., Abrous, D. N., Mendizabal-Zubiaga, J., Grandes, P., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.037 · Cited by 514
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
Maresz, K., Carrier, E. J., Ponomarev, E. D., Hillard, C. J., & Dittel, B. N. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03380.x · Cited by 482
Patel, S., Roelke, C. T., Rademacher, D. J., Cullinan, W. E., & Hillard, C. J. (2004) · Endocrinology · doi:10.1210/en.2004-0638 · Cited by 475
Gao, Y., Vasilyev, D. V., Goncalves, M. B., Howell, F. V., Hobbs, C., Reisenberg, M., Shen, R., Zhang, M.-Y., Strassle, B. W., Lu, P., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5693-09.2010 · Cited by 473
Tanimura, A., Yamazaki, M., Hashimotodani, Y., Uchigashima, M., Kawata, S., Abe, M., Kita, Y., Hashimoto, K., Shimizu, T., Watanabe, M., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.021 · Cited by 472
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors
Marrs, W. R., Blankman, J. L., Horne, E. A., Thomazeau, A., Lin, Y. H., Coy, J., Bodor, A. L., Muccioli, G. G., Hu, S. S.-J., Woodruff, G., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2601 · Cited by 441
Self-citationJin, K., Sun, Y., Xie, L., Batteur, S., Mao, X. O., Smelick, C., Logvinova, A., & Greenberg, D. A. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00046.x · Cited by 396
Cadas, H., di Tomaso, E., & Piomelli, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-04-01226.1997 · Cited by 396
Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling
Puighermanal, E., Marsicano, G., Busquets-Garcia, A., Lutz, B., Maldonado, R., & Ozaita, A. (2009) · Nature Neuroscience · doi:10.1038/nn.2369 · Cited by 385
The Chronic Effects of Cannabis on Memory in Humans: A Review
Solowij, N., & Battisti, R. (2008) · Current Drug Abuse Reviewse · doi:10.2174/1874473710801010081 · Cited by 380
Gonsiorek, W., Lunn, C., Fan, X., Narula, S., Lundell, D., & Hipkin, R. W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26516-0 · Cited by 369
Kozak, K. R., Crews, B. C., Morrow, J. D., Wang, L.-H., Ma, Y. H., Weinander, R., Jakobsson, P.-J., & Marnett, L. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206788200 · Cited by 368
Maresz, K., Pryce, G., Ponomarev, E. D., Marsicano, G., Croxford, J. L., Shriver, L. P., Ledent, C., Cheng, X., Carrier, E. J., Mann, M. K., et al. (2007) · Nature Medicine · doi:10.1038/nm1561 · Cited by 363
Endocrine regulation of ageing
Russell, S. J., & Kahn, C. R. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2234 · Cited by 356
Wang, L., Liu, J., Harvey-White, J., Zimmer, A., & Kunos, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336351100 · Cited by 340
Self-citationHuang, S. M., Bisogno, T., Petros, T. J., Chang, S. Y., Zavitsanos, P. A., Zipkin, R. E., Sivakumar, R., Coop, A., Maeda, D. Y., De Petrocellis, L., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107351200 · Cited by 339
Self-citationLUNDQVIST, T. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.02.017 · Cited by 331
The endocannabinoid system drives neural progenitor proliferation
Aguado, T., Monory, K., Palazuelos, J., Stella‡, N., Cravatt, B., Lutz, B., Marsicano, G., Kokaia, Z., Guzmán, M., & Galve‐Roperh, I. (2005) · The FASEB Journal · doi:10.1096/fj.05-3995fje · Cited by 327
Self-citationMultiple pathways involved in the biosynthesis of anandamide
Liu, J., Wang, L., Harvey-White, J., Huang, B. X., Kim, H.-Y., Luquet, S., Palmiter, R. D., Krystal, G., Rai, R., Mahadevan, A., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.020 · Cited by 304
Lipofuscin: formation, effects and role of macroautophagy
Höhn, A., & Grune, T. (2013) · Redox Biology · doi:10.1016/j.redox.2013.01.006 · Cited by 298
Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation
Bouaboula, M., Hilairet, S., Marchand, J., Fajas, L., Fur, G. L., & Casellas, P. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.05.032 · Cited by 298
Presence of cannabinoid binding sites in the brain from early postnatal ages
de Fonseca, F. R., Ramos, J. A., Bonnin, A., & Fernández-Ruiz, J. J. (1993) · NeuroReport · doi:10.1097/00001756-199302000-00005 · Cited by 297
Berrendero, F., Sepe, N., Ramos, J. A., Di Marzo, V., & Fern�ndez-Ruiz, J. J. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990901)33:3<181::aid-syn3>3.0.co;2-r · Cited by 289
Self-citationWestlake, T. M., Howlett, A. C., Bonner, T. I., Matsuda, L. A., & Herkenham, M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90511-8 · Cited by 283
Taschler, U., Radner, F. P. W., Heier, C., Schreiber, R., Schweiger, M., Schoiswohl, G., Preiss-Landl, K., Jaeger, D., Reiter, B., Koefeler, H. C., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.215434 · Cited by 282
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis
Witte, M. E., Mahad, D. J., Lassmann, H., & van Horssen, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.11.007 · Cited by 278
Defective Adult Neurogenesis in CB1 Cannabinoid Receptor Knockout Mice
Jin, K., Xie, L., Kim, S. H., Parmentier-Batteur, S., Sun, Y., Mao, X. O., Childs, J., & Greenberg, D. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.2.204 · Cited by 273
Endocannabinoid signaling in microglial cells
Stella, N. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.037 · Cited by 272
Self-citationMonoacylglycerol Lipase Is a Therapeutic Target for Alzheimer's Disease
Chen, R., Zhang, J., Wu, Y., Wang, D., Feng, G., Tang, Y.-P., Teng, Z., & Chen, C. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.030 · Cited by 271
Tortoriello, G., Morris, C. V., Alpar, A., Fuzik, J., Shirran, S. L., Calvigioni, D., Keimpema, E., Botting, C. H., Reinecke, K., Herdegen, T., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201386035 · Cited by 255
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators
Alhouayek, M., & Muccioli, G. G. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.03.001 · Cited by 252
Endocannabinoid-mediated retrograde modulation of synaptic transmission
Ohno-Shosaku, T., & Kano, M. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.017 · Cited by 243
Targeting the endocannabinoid system in the treatment of fragile X syndrome
Busquets-Garcia, A., Gomis-González, M., Guegan, T., Agustín-Pavón, C., Pastor, A., Mato, S., Pérez-Samartín, A., Matute, C., de la Torre, R., Dierssen, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3127 · Cited by 241
Simon, G. M., & Cravatt, B. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707807200 · Cited by 228
Verbal learning and memory in adolescent cannabis users, alcohol users and non-users
Solowij, N., Jones, K. A., Rozman, M. E., Davis, S. M., Ciarrochi, J., Heaven, P. C. L., Lubman, D. I., & Yücel, M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2203-x · Cited by 226
van der Stelt, M., Mazzola, C., Esposito, G., Matias, I., Petrosino, S., Filippis, D. D., Micale, V., Steardo, L., Drago, F., Iuvone, T., et al. (2006) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-006-6037-3 · Cited by 224
Non‐psychoactive CB 2 cannabinoid agonists stimulate neural progenitor proliferation
Palazuelos, J., Aguado, T., Egia, A., Mechoulam, R., Guzmán, M., Galve‐Roperh, I., Palazuelos, J., Aguado, T., Egia, A., Mechoulam, R., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6164fje · Cited by 221
Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease
Mulder, J., Zilberter, M., Pasquaré, S. J., Alpár, A., Schulte, G., Ferreira, S. G., Köfalvi, A., Martín-Moreno, A. M., Keimpema, E., Tanila, H., et al. (2011) · Brain · doi:10.1093/brain/awr046 · Cited by 210
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease
Blázquez, C., Chiarlone, A., Sagredo, O., Aguado, T., Pazos, M. R., Resel, E., Palazuelos, J., Julien, B., Salazar, M., Börner, C., et al. (2011) · Brain · doi:10.1093/brain/awq278 · Cited by 201
van der Stelt, M., Fox, S. H., Hill, M., Crossman, A. R., Petrosino, S., Di Marzo, V., & Brotchie, J. M. (2005) · The FASEB Journal · doi:10.1096/fj.04-3010fje · Cited by 199
Self-citationMorgese, M. G., Cassano, T., Cuomo, V., & Giuffrida, A. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.021 · Cited by 196
The major central endocannabinoid directly acts at GABAAreceptors
Sigel, E., Baur, R., Rácz, I., Marazzi, J., Smart, T. G., Zimmer, A., & Gertsch, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113444108 · Cited by 186
Self-citationCNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity
Onaivi, E. S., Ishiguro, H., Gu, S., & Liu, Q.-R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111400652 · Cited by 184
The endocannabinoid system in targeting inflammatory neurodegenerative diseases
Centonze, D., Finazzi-Agrò, A., Bernardi, G., & Maccarrone, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.004 · Cited by 182
Goncalves, M. B., Suetterlin, P., Yip, P., Molina-Holgado, F., Walker, D. J., Oudin, M. J., Zentar, M. P., Pollard, S., Yáñez-Muñoz, R. J., Williams, G., et al. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.05.001 · Cited by 177
Transport of endocannabinoids across the plasma membrane and within the cell
Fowler, C. J. (2013) · The FEBS Journal · doi:10.1111/febs.12212 · Cited by 168
Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors
Bilkei-Gorzo, A., Racz, I., Valverde, O., Otto, M., Michel, K., Sarstre, M., & Zimmer, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504640102 · Cited by 165
Self-citationThe endocannabinoid system in normal and pathological brain ageing
Bilkei‐Gorzó, A. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0388 · Cited by 165
Bilsland, L. G., Dick, J. R. T., Pryce, G., Petrosino, S., Di Marzo, V., Baker, D., Greensmith, L., Bilsland, L. G., Dick, J. R. T., Pryce, G., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4743fje · Cited by 164
Self-citationA restricted population of CB 1 cannabinoid receptors with neuroprotective activity
Chiarlone, A., Bellocchio, L., Blázquez, C., Resel, E., Soria-Gómez, E., Cannich, A., Ferrero, J. J., Sagredo, O., Benito, C., Romero, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400988111 · Cited by 162
Antistress Effect of TRPV1 Channel on Synaptic Plasticity and Spatial Memory
Li, H.-B., Mao, R.-R., Zhang, J.-C., Yang, Y., Cao, J., & Xu, L. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.02.020 · Cited by 161
Cannabinoid receptors and the regulation of bone mass
Bab, I., & Zimmer, A. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707593 · Cited by 161
Self-citationKim, K., Moore, D. H., Makriyannis, A., & Abood, M. E. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.05.025 · Cited by 153
Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons
Cristino, L., Busetto, G., Imperatore, R., Ferrandino, I., Palomba, L., Silvestri, C., Petrosino, S., Orlando, P., Bentivoglio, M., Mackie, K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219485110 · Cited by 143
Self-citationLastres‐Becker, I., de Miguel, R., PETROCELLIS, L. D., Makriyannis, A., Marzo, V. D., & Fernández‐Ruíz, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01595.x · Cited by 142
Inhibition of COX‐2 expression by endocannabinoid 2‐arachidonoylglycerol is mediated via PPAR‐γ
Du, H., Chen, X., Zhang, J., & Chen, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01444.x · Cited by 136
Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure
Cutando, L., Busquets-García, A., Puighermanal, E., Gomis‐González, M., Delgado-Garcia, J. M., Gruart, A., Maldonado, R. J., & Ozaita, A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67569 · Cited by 136
Bouchard, J. J., Truong, J. K., Bouchard, K. E., Dunkelberger, D. L., Desrayaud, S., Moussaoui, S. M., Tabrizi, S. J., Stella, N., & Muchowski, P. J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4008-12.2012 · Cited by 135
Self-citationRole of CB1 cannabinoid receptors on GABAergic neurons in brain aging
Albayram, Ö., Alferink, J., Pitsch, J., Piyanova, A., Neitzert, K., Poppensieker, K., Mauer, D., Michel, K., Legler, A., Becker, A. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016442108 · Cited by 135
Self-citationNeuron‐type specific cannabinoid‐mediated G protein signalling in mouse hippocampus
Steindel, F., Lerner, R., Häring, M., Ruehle, S., Marsicano, G., Lutz, B., & Monory, K. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12137 · Cited by 133
Prospects for cannabinoid therapies in basal ganglia disorders
Fernández‐Ruíz, J., Moreno‐Martet, M., Rodríguez‐Cueto, C., Palomo‐Garo, C., Gómez‐Cañas, M., Valdeolivas, S., Guaza, C., Romero, J., Guzmán, M., Mechoulam, R., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01365.x · Cited by 127
Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex
Long, L. E., Lind, J., Webster, M. J., & Weickert, C. S. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-87 · Cited by 127
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation
Zoppi, S., Perez‐Nievas, B. G., Madrigal, J. L. M., Manzanares, J., Leza, J. C., & García‐Bueno, B. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.214 · Cited by 125
Amnesia induced by β-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade
Mazzola, C., Micale, V., & Drago, F. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.026 · Cited by 122
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults
Chen, X., Zhang, J., & Chen, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.024 · Cited by 122
González, S. R., Scorticati, C., Garcı́a-Arencibia, M., de Miguel, R., Ramos, J. A., & Fernández‐Ruíz, J. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.014 · Cited by 118
Hegde, V. L., Nagarkatti, M., & Nagarkatti, P. S. (2010) · European Journal of Immunology · doi:10.1002/eji.201040667 · Cited by 117
Dowie, M. J., Bradshaw, H. B., Howard, M. L., Nicholson, L. F. B., Faull, R. L. M., Hannan, A. J., & Glass, M. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.014 · Cited by 113
González-Aparicio, R., & Moratalla, R. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.008 · Cited by 112
Cerebellar white-matter changes in cannabis users with and without schizophrenia
Solowij, N., Yücel, M., Respondek, C., Whittle, S., Lindsay, E., Pantelis, C., & Lubman, D. I. (2011) · Psychological Medicine · doi:10.1017/s003329171100050x · Cited by 112
Naydenov, A. V., Horne, E. A., Cheah, C. S., Swinney, K., Hsu, K., Cao, J. K., Marrs, W., Blankman, J. L., Tu, S., Cherry, A. E., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.06.030 · Cited by 111
Self-citationDissociation of the Pharmacological Effects of THC by mTOR Blockade
Puighermanal, E., Busquets-García, A., Gomis‐González, M., Marsicano, G., Maldonado, R. J., & Ozaita, A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.31 · Cited by 109
TRPV1: a stress response protein in the central nervous system.
Ho, K. W., Ward, N. J., & Calkins, D. J. (2012) · Europe PMC (PubMed Central) · Cited by 106
Endocannabinoids via CB 1 receptors act as neurogenic niche cues during cortical development
Díaz-Alonso, J., Guzmán, M., & Galve‐Roperh, I. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0385 · Cited by 105
Plasma endocannabinoid levels in multiple sclerosis
Jean-Gilles, L., Feng, S., Tench, C. R., Chapman, V., Kendall, D. A., Barrett, D. A., & Constantinescu, C. S. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.07.021 · Cited by 100
Huntington's disease in children: Neuropathologic study of four cases
Byers, R. K., Gilles, F. H., & Fung, C. (1973) · Neurology · doi:10.1212/wnl.23.6.561 · Cited by 97
Signal Transduction via Cannabinoid Receptors
Dalton, G. D., Bass, C. E., Horn, C. V., & Howlett, A. C. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824615 · Cited by 95
At the crossroad between immunity and metabolism: focus on leptin
Conde, J., Scotece, M., Gómez, R., Gómez-Reino, J. J., Lago, F., & Gualillo, O. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.48 · Cited by 92
Sarnataro, D., Grimaldi, C., Pisanti, S., Gazzerro, P., Laezza, C., Zurzolo, C., & Bifulco, M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.10.016 · Cited by 91
Woodward, D. F., Carling, R. W., Cornell, C. L., Fliri, H. G., Martos, J. L., Pettit, S. N., Liang, Y., & Wang, J. W. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.001 · Cited by 91
Hypothalamic mTOR: The Rookie Energy Sensor
de Morentin, P. B. M., Martínez‐Sánchez, N., Roa, J., Fernø, J., Nogueiras, R., Tena‐Sempere, M., Diéguez, C., & López, M. (2014) · Current Molecular Medicine · doi:10.2174/1566524013666131118103706 · Cited by 91
Leptin as a metabolic link to multiple sclerosis
Matarese, G., Carrieri, P. B., Montella, S., Rosa, V. D., & Cava, A. L. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.89 · Cited by 90
Arévalo‐Martín, Á., García‐Ovejero, D., Rubio‐Araiz, A., Gómez, O., Molina‐Holgado, F., & Molina‐Holgado, E. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05782.x · Cited by 88
Valdeolivas, S., Pazos, M. R., Bisogno, T., Piscitelli, F., Iannotti, F. A., Allarà, M., Sagredo, O., Marzo, V. D., & Fernández‐Ruíz, J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.387 · Cited by 87
Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats
Berrendero, F., Romero, J., García-Gil, L., Suarez, I., la Cruz, P. D., Ramos, J. A., & Fernández‐Ruíz, J. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(98)00042-8 · Cited by 86
Choi, K. H., Le, T., McGuire, J. L., Xing, G., Zhang, L., Li, H., Parker, C. C., Johnson, L. R., & Ursano, R. J. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.021 · Cited by 84
Gyrification brain abnormalities associated with adolescence and early-adulthood cannabis use
Mata, I. F., Pérez‐Iglesias, R., Roiz‐Santiáñez, R., Tordesillas‐Gutiérrez, D., Pazos, Á., Gutiérrez, A., Vázquez‐Barquero, J. L., & Crespo‐Facorro, B. (2010) · Brain Research · doi:10.1016/j.brainres.2009.12.069 · Cited by 83
Oudin, M. J., Hobbs, C., & Doherty, P. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07831.x · Cited by 81
Hu, S. S., Bradshaw, H. B., Benton, V. M., Chen, J. S.-C., Huang, S. M., Minassi, A., Bisogno, T., Masuda, K. R., Tan, B., Roskoski, R. J., et al. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.05.026 · Cited by 80
Verhoeckx, K. C. M., Voortman, T., Balvers, M. G. J., Hendriks, H., Wortelboer, H. M., & Witkamp, R. F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.07.008 · Cited by 79
Rossi, S., Furlan, R., Chiara, V. D., Muzio, L., Musella, A., Motta, C., Studer, V., Cavasinni, F., Bernardi, G., Martino, G., et al. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.017 · Cited by 78
TRB3 links ER stress to autophagy in cannabinoid antitumoral action
Salazar‐Roa, M., Carracedo, A., Salanueva, Í. J., Hernández‐Tiedra, S., Egia, A., Lorente, M., Vázquez, P., Torres, S., Iovanna, J., Guzmán, M., et al. (2009) · Autophagy · doi:10.4161/auto.5.7.9508 · Cited by 76
Aging and neurogenesis in the adult forebrain: what we have learned and where we should go from here
Hamilton, L. K., Joppé, S. E., Cochard, L. M., & Fernandes, K. J. L. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12207 · Cited by 75
Morishita, J., Okamoto, Y., Tsuboi, K., Ueno, M., Sakamoto, H., Nobuhiro Maekawa, A., & Ueda, N. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03234.x · Cited by 70
Bilkei‐Gorzó, A., Drews, E., Albayram, Ö., Piyanova, A., Gaffal, E., Tueting, T., Michel, K., Mauer, D., Maier, W., & Zimmer, A. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.009 · Cited by 64
Self-citationRazavinasab, M., Shamsizadeh, A., Shabani, M., Nazeri, M., Allahtavakoli, M., Asadi‐Shekaari, M., Esmaeili‐Mahani, S., & Sheibani, V. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12015 · Cited by 59
Wenger, T., Gerendai, I., Fezza, F., González, S. R., Bisogno, T., Fernández‐Ruíz, J., & Marzo, V. D. (2002) · Life Sciences · doi:10.1016/s0024-3205(01)01516-8 · Cited by 58
Cannabinoid receptors in developing rats: detection of mRNA and receptor binding
McLaughlin, C., Martin, B. R., Compton, D. R., & Abood, M. E. (1994) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(94)90006-x · Cited by 56
Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons
Noonan, J., Tanveer, R., Klompas, A. M., Gowran, A., McKiernan, J., & Campbell, V. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.162040 · Cited by 55
Naydenov, A. V., Sepers, M. D., Swinney, K., Raymond, L. A., Palmiter, R. D., & Stella, N. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.009 · Cited by 53
Self-citationType I Cannabinoid Receptor Trafficking: All Roads Lead to Lysosome
Rozenfeld, R. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01130.x · Cited by 51
Horne, E. A., Coy, J. W., Swinney, K., Fung, S., Cherry, A. E., Marrs, W., Naydenov, A. V., Lin, Y. H., Sun, X., Keene, C. D., et al. (2012) · European Journal of Neuroscience · doi:10.1111/ejn.12045 · Cited by 49
Self-citationCannabinoid receptor 1 modulates the autophagic flux independent of mTOR‐ and BECLIN1‐complex
Hiebel, C., Kromm, T., Stark, M., & Behl, C. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12839 · Cited by 48
In vitro and in vivo models of H untington's disease show alterations in the endocannabinoid system
Bari, M., Battista, N., Valenza, M., Mastrangelo, N., Malaponti, M., Catanzaro, G., Centonze, D., Finazzi‐Agrò, A., Cattaneo, E. F., & Maccarrone, M. (2013) · FEBS Journal · doi:10.1111/febs.12329 · Cited by 45
Webb, M., Luo, L., Jing, Y., & Tham, C. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.04.090 · Cited by 44
Morozov, Y. M., Dominguez, M. H., Varela, L., Shanabrough, M., Koch, M., Horváth, T. L., & RAKIC, P. T. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12237 · Cited by 43
Johnston, T. H., Huot, P., Fox, S. H., WAKEFIELD, J. D., Sykes, K. A., Bartolini, W. P., Milne, G. T., Pearson, J. P., & Brotchie, J. M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.169532 · Cited by 40
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review
Velayudhan, L., van Diepen, E., Marudkar, M., Hands, O., Suribhatla, S., Prettyman, R. J., Murray, J., Baillon, S. F., & Bhattacharyya, S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990434 · Cited by 39
Pryce, G., Cabranes, A., Fernández‐Ruíz, J., Bisogno, T., Marzo, V. D., Long, J. Z., Cravatt, B., Giovannoni, G., & Baker, D. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513485982 · Cited by 38
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium
Koay, L. C., Rigby, R. J., & Wright, K. L. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00317.2013 · Cited by 38
Modulation of T-type calcium channels by bioactive lipids
Chemin, J., Cazade, M., & Lory, P. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1467-5 · Cited by 35
Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory
Albayram, Ö., Bilkei‐Gorzó, A., & Zimmer, A. (2012) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2012.00034 · Cited by 34
Self-citationPiyanova, A., Albayram, Ö., Rossi, C. A., Farwanah, H., Michel, K., Nicotera, P., Sandhoff, K., & Bilkei‐Gorzó, A. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.08.001 · Cited by 32
Cannabis based drug is licensed for spasticity in patients with MS
Kmietowicz, Z. (2010) · BMJ · doi:10.1136/bmj.c3363 · Cited by 23
Cited by
Zou, S., & Kumar, U. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030833 · Cited by 1,343
The endocannabinoid system in guarding against fear, anxiety and stress
Lutz, B., Marsicano, G., Maldonado, R., & Hillard, C. J. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn4036 · Cited by 506
Bioactive Lipids and Chronic Inflammation: Managing the Fire Within
Chiurchiù, V., Leuti, A., & Maccarrone, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00038 · Cited by 427
Layé, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014092 · Cited by 420
Endocannabinoids–at the crossroads between the gut microbiota and host metabolism
Cani, P. D., Plovier, H., Van Hul, M., Geurts, L., Delzenne, N. M., Druart, C., & Everard, A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.211 · Cited by 367
Metadata
- Authors
- Di Marzo, V., Stella, N., & Zimmer, A.
- Venue
- Nature Reviews Neuroscience
- Published
- 2014-12-19
- Volume
- 16
- Issue
- 1
- Pages
- 30-42
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2014980565
- Cited by
- 382
- References
- 151
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.